Clinical Trial Update: MDR - PMCF Study for Taperloc Complete Stems

View source ↗

Summary

The update indicates that the MDR PMCF study for the Taperloc Complete Stem hip prosthesis by Zimmer Biomet is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Disorders
• Hip Fracture
• Hip Injuries
• Hip Pain
• Osteoarthritis of the Hip

Drugs mentioned

• Taperloc Complete Stem

Snippet

Sponsor: Zimmer Biomet | Conditions: Hip Arthritis, Hip Disease | Status: RECRUITING